{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:59:39Z","timestamp":1648778379507},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.1532\/ijh97.e0303","type":"journal-article","created":{"date-parts":[[2005,2,22]],"date-time":"2005-02-22T19:39:43Z","timestamp":1109101183000},"page":"155-158","source":"Crossref","is-referenced-by-count":2,"title":["Successful Salvage with High-Dose Sequential Chemotherapy Coupled with In Vivo Purging and Autologous Stem Cell Transplantation in 2 Patients with Primary Refractory Mantle Cell Lymphoma Presenting in the Leukemic Phase"],"prefix":"10.1007","volume":"81","author":[{"given":"Basak","family":"Oyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yener","family":"Koc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin","family":"Kansu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.thj.6200007","volume":"1","author":"Dreger, P","year":"2000","unstructured":"Dreger P, Martin S, Kuse R, et al. The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients. Hematol J. 2000;1:87-94.","journal-title":"Hematol J"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"Argatoff, LH","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89:2067-2078.","journal-title":"Blood"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","author":"Armitage, JO","year":"1998","unstructured":"Armitage JO, Weisenburger DD. New approaches to classifying non-Hodgkin's lymphoma: clinical features of the major subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-2795.","journal-title":"J Clin Oncol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","author":"Weisenburger, DD","year":"1996","unstructured":"Weisenburger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood. 1996;87:4483-4494.","journal-title":"Blood"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.1998.16.5.1922","volume":"16","author":"Hiddemann, W","year":"1998","unstructured":"Hiddemann W, Unterhalt M, Herrmann R, et al. Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective compared analysis of the German Low-Grade Lymphoma Study Group. J Clin Oncol. 1998;16:1922-1930.","journal-title":"J Clin Oncol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/sonc.2002.30143","author":"Mangel, J","year":"2002","unstructured":"Mangel J, Buckstein R, Imrie K, et al. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Semin Oncol. 2002;29(suppl 2):56-69.","journal-title":"Semin Oncol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1083-8791(00)70030-9","author":"Vose, JM","year":"2000","unstructured":"Vose JM, Bierman PF, Weisenburger DD, et al. Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant. 2000;6:640-645.","journal-title":"Biol Blood Marrow Transplant"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1008325212484","author":"Rummel, MJ","year":"1999","unstructured":"Rummel MJ, Chow KU, Jager E, et al. Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse. Ann Oncol. 1999;10:115-117.","journal-title":"Ann Oncol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.1998.16.1.13","author":"Freedman, AS","year":"1998","unstructured":"Freedman AS, Neuberg D, Gribben JG, et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle cell lymphoma: no evidence for long-term remission. J Clin Oncol. 1998; 16:13-18.","journal-title":"J Clin Oncol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","author":"Khouri, IF","year":"1998","unstructured":"Khouri IF, Romaguera J, Kantarjian H, et al. Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol. 1998;16:3803-3809.","journal-title":"J Clin Oncol"},{"key":"E00011","first-page":"482a","author":"Vanderberghe, E","year":"2000","unstructured":"Vanderberghe E, Ruiz de Elvira C, Isaacson P, et al. Does transplantation improve outcome in mantle cell lymphoma? A study from the EBMT [abstract]. Blood. 2000;96:482a.","journal-title":"Blood"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/10428199809092678","author":"Freedman, AS","year":"1998","unstructured":"Freedman AS, Gribben JG, Nadler LM. High dose therapy and autologous stem cell transplantation in follicular non-Hodgkin's lymphoma. Leuk Lymphoma. 1998;28:219-230.","journal-title":"Leuk Lymphoma"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","volume":"96","author":"Magni, M","year":"2000","unstructured":"Magni M, Di Nicola M, Devizzi L, et al. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion. Blood. 2000;96:864-869.","journal-title":"Blood"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2141.2002.03256.x","volume":"116","author":"Lazzarino, M","year":"2002","unstructured":"Lazzarino M, Arcaini L, Bernasconi P, et al. A sequence of immuno-chemotherapy with rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma. Br J Haematol. 2002;116:229-235.","journal-title":"Br J Haematol"},{"key":"E00015","first-page":"459a","author":"Molina, A","year":"1998","unstructured":"Molina A, Nademanee A, O'Donnel MR, et al. Autologous and allogeneic stem cell transplantation for poor-risk mantle cell lymphoma: the City of Hope experience [abstract]. Blood. 1998;92: 459a.","journal-title":"Blood"},{"key":"E00016","first-page":"482a","volume":"96","author":"Brugger, W","year":"2000","unstructured":"Brugger W, Hirsch J, Repp R, et al. Treatment of follicular and mantle cell non-Hodgkin's lymphoma with anti-CD20 antibody rituximab after high-dose chemotherapy with autologous CD34 enriched peripheral blood stem cell transplantation [abstract]. Blood. 2000;96:482a.","journal-title":"Blood"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V89.2.724","author":"Corradini, P","year":"1997","unstructured":"Corradini P, Astolfi M, Cherasco C, et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood. 1997;89: 724-731.","journal-title":"Blood"},{"key":"E00018","first-page":"1002","volume":"84","author":"Zinzani, PL","year":"1999","unstructured":"Zinzani PL, Magagnoli M, Moretti L, et al. Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients. Haematologica. 1999;84:1002-1006.","journal-title":"Haematologica"},{"key":"E00019","first-page":"168","author":"Zinzani, PL","year":"1996","unstructured":"Zinzani PL, Bebdandi M, Gherlinzoni F, Merla E, Gozzetti A, Tura S. FLU-ID (fludarabine and idarubicin) regimen as salvage therapy in pretreated low-grade non-Hodgkin's lymphoma. Haematologica. 1996;81:168-171.","journal-title":"Haematologica"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.E0303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T21:47:08Z","timestamp":1586123228000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.E0303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2,1]]}},"alternative-id":["H7YE3JRWCU7NMT2J"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.e0303","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2,1]]}}}